Span Divergent has scheduled its 46th Annual General Meeting for September 28, 2026, to adopt the audited financial statements for the fiscal year ended March 31, 2026. The company reported a significant rise in consolidated revenue, which grew 92.24% year-on-year to ₹1,722.46 lakh from ₹896.01 lakh in the previous year.

Despite the revenue growth, the consolidated loss attributable to owners widened by approximately 172.67% to ₹250.15 lakh compared to ₹91.73 lakh in FY25. On a standalone basis, the company reported a profit after tax of ₹72.64 lakh, down from ₹83.96 lakh in the prior year.

Financial Performance

The divergence between standalone and consolidated results highlights the operational challenges within specific subsidiaries. While the holding company remained profitable, subsidiaries such as Dryfruit Factory LLP and Biospan Contamination Control Solutions Private Limited contributed significantly to the consolidated loss.

Dryfruit Factory LLP, a key subsidiary involved in cashew processing, reported revenue of ₹1,367.57 lakh but incurred a net loss of ₹269.22 lakh. This contrasts with Biospan Scientific LLP, which posted a net profit of ₹2.32 lakh on revenue of ₹243.37 lakh.

What the Numbers Show

The financial data reveals a stark contrast between top-line growth and bottom-line erosion at the group level. While consolidated revenue nearly doubled, driven largely by increased trading and cashew-processing activity, the operating costs and losses in specific segments outpaced this growth. The standalone entity's ability to generate profit despite a decline in its own revenue suggests that the consolidated loss is heavily influenced by the performance of its subsidiaries rather than the holding company's core operations.

Corporate Actions and Governance

The AGM agenda includes several special resolutions. Shareholders will vote on the continuation of directorship for Mr. Sanjay Mehta, who has attained the age of 75 years, in compliance with Regulation 17(1A) of the SEBI Listing Regulations. Additionally, the meeting will seek approval for related party transactions with entities including Dryfruit Factory LLP and Aranya Consulting and Biotech LLP, with maximum per annum values ranging from ₹5 crore to ₹75 crore.

The board decided not to recommend any dividend for FY26, aiming to conserve resources for future plans. The company also issued 18,01,481 equity shares on a preferential basis during the year, raising proceeds that remained unutilized as of March 31, 2026.

Span Divergent reported a consolidated net loss of ₹118.82 lakhs for the first quarter ended June 30, 2026 (Q1FY27), marking a significant deterioration from the consolidated net loss of ₹17.01 lakhs in the corresponding period of FY26. The widening deficit was primarily driven by severe underperformance in its core cashew processing segment, where revenue plummeted while operating losses expanded sharply. Standalone operations also turned negative, reporting a net loss of ₹4.22 lakhs compared to a net profit of ₹41.67 lakhs in Q1FY26, signaling broader operational challenges across the group.

The Board of Directors approved the unaudited integrated financial results on August 11, 2026. The figures were reviewed by the Audit Committee and subjected to a limited review by statutory auditors Y. B. Desai & Associates, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were published in Financial Express and Dhabkar on August 12, 2026, in compliance with Regulation 47.

Consolidated Financial Performance

Consolidated revenue from operations dropped to ₹102.55 lakhs in Q1FY27, down from ₹126.61 lakhs in Q1FY26. This decline was largely attributed to the cashew processing segment, which generated only ₹35.41 lakhs in revenue, a fraction of the ₹379.56 lakhs recorded in the preceding quarter (Q4FY26). The trading segment contributed ₹67.14 lakhs, down from ₹111.34 lakhs in the year-ago quarter. Total expenses stood at ₹244.77 lakhs, leading to an operating loss before interest and tax of ₹114.57 lakhs. Finance costs increased to ₹13.67 lakhs from ₹11.92 lakhs in Q1FY26, while deferred tax expense added ₹4.25 lakhs to bottom-line pressure.

Standalone Results and Subsidiary Issues

On a standalone basis, total income fell to ₹30.83 lakhs from ₹64.93 lakhs in Q1FY26. Other operating income, comprising interest on fluctuating capital provided to LLP subsidiaries and management fees, declined to ₹13.45 lakhs from ₹38.45 lakhs. Total expenses rose to ₹46.56 lakhs from ₹41.19 lakhs, largely due to higher other expenses of ₹14.00 lakhs compared to ₹7.99 lakhs in the prior year.

The company disclosed significant challenges within its subsidiaries. Aranya Consulting and Biotech LLP had accumulated losses of ₹1,494 lakhs as of March 31, 2026. Biospan Contamination Control Solutions Pvt. Ltd reported accumulated losses of ₹742 lakhs as of June 30, 2026, with total liabilities exceeding total assets by ₹752 lakhs. Despite these deficits, management continues to prepare financial results on a going concern basis, citing plans for product introductions and potential business tie-ups to revive operations.

What the Numbers Show

The divergence between standalone and consolidated performance highlights the heavy drag from subsidiary operations. While the standalone entity managed to contain its loss to ₹4.22 lakhs through lower income but controlled core expenses, the consolidated group absorbed massive operating losses from the cashew processing unit. The cashew segment incurred a pre-tax loss of ₹81.93 lakhs despite generating ₹35.41 lakhs in revenue, indicating a fundamental mismatch between current scale and fixed cost structures. Furthermore, unutilized proceeds of ₹127.04 lakhs from the March 2026 preferential issue remain available for stated objects, including raw cashew nut inventory procurement, suggesting management intends to ramp up working capital to address these operational gaps.